' Most Confusing ' Desmoid Tumors: Pazopanib Now an Option? ' Most Confusing ' Desmoid Tumors: Pazopanib Now an Option?

Several treatment options have been described for desmoid tumors, but none is approved. Now the French Sarcoma Group is adding pazopanib to the list, but this is premature, says an expert.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news